HIV care for geographically mobile populations

Barbara Taylor, L. Sergio Garduño, Emily V. Reyes, Raziel Valiño, Rita Rojas, Yeycy Donastorg, Karen Brudney, Jennifer Hirsch

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The interaction between geographic mobility and risk for human immunodeficiency virus infection is well recognized, but what happens to those same individuals, once infected, as they transition to living with the infection? Does mobility affect their transition into medical care? If so, do mobile and nonmobile populations achieve similar success with antiretroviral treatment? The definition of mobility has changed over the centuries to encompass a complex phenotype including permanent migration, frequent travel, circular migration, and travel to and from treatment centers. The heterogeneity of these definitions leads to discordant findings. Investigations show that mobility has an impact on infection risk, but fewer data exist on the impact of geographic mobility on medical care and treatment outcomes. This review will examine existing data regarding the impact of geographic mobility on access to and maintenance in medical care and on adherence to antiretroviral therapy for those living with human immunodeficiency virus infection. It will also expand the concept of mobility to include data on the impact of the distance from residence to clinic on medical care and treatment adherence. Our conclusions are that the existing literature is limited by varying definitions of mobility and the inherent oversimplification necessary to apply a "mobility measure" in a statistical analysis. The impact of mobility on antiretroviral treatment outcomes deserves further exploration to both define the phenomenon and target interventions to these at-risk populations.

Original languageEnglish (US)
Pages (from-to)342-351
Number of pages10
JournalMount Sinai Journal of Medicine
Volume78
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Virus Diseases
HIV
Infection
Population
Maintenance
Phenotype
Therapeutics

Keywords

  • antiretroviral treatment
  • geographic mobility
  • human immunodeficiency virus HIV
  • mobile population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Taylor, B., Garduño, L. S., Reyes, E. V., Valiño, R., Rojas, R., Donastorg, Y., ... Hirsch, J. (2011). HIV care for geographically mobile populations. Mount Sinai Journal of Medicine, 78(3), 342-351. https://doi.org/10.1002/msj.20255

HIV care for geographically mobile populations. / Taylor, Barbara; Garduño, L. Sergio; Reyes, Emily V.; Valiño, Raziel; Rojas, Rita; Donastorg, Yeycy; Brudney, Karen; Hirsch, Jennifer.

In: Mount Sinai Journal of Medicine, Vol. 78, No. 3, 05.2011, p. 342-351.

Research output: Contribution to journalArticle

Taylor, B, Garduño, LS, Reyes, EV, Valiño, R, Rojas, R, Donastorg, Y, Brudney, K & Hirsch, J 2011, 'HIV care for geographically mobile populations', Mount Sinai Journal of Medicine, vol. 78, no. 3, pp. 342-351. https://doi.org/10.1002/msj.20255
Taylor B, Garduño LS, Reyes EV, Valiño R, Rojas R, Donastorg Y et al. HIV care for geographically mobile populations. Mount Sinai Journal of Medicine. 2011 May;78(3):342-351. https://doi.org/10.1002/msj.20255
Taylor, Barbara ; Garduño, L. Sergio ; Reyes, Emily V. ; Valiño, Raziel ; Rojas, Rita ; Donastorg, Yeycy ; Brudney, Karen ; Hirsch, Jennifer. / HIV care for geographically mobile populations. In: Mount Sinai Journal of Medicine. 2011 ; Vol. 78, No. 3. pp. 342-351.
@article{9c827a3d65994b12aab0d52d21abb852,
title = "HIV care for geographically mobile populations",
abstract = "The interaction between geographic mobility and risk for human immunodeficiency virus infection is well recognized, but what happens to those same individuals, once infected, as they transition to living with the infection? Does mobility affect their transition into medical care? If so, do mobile and nonmobile populations achieve similar success with antiretroviral treatment? The definition of mobility has changed over the centuries to encompass a complex phenotype including permanent migration, frequent travel, circular migration, and travel to and from treatment centers. The heterogeneity of these definitions leads to discordant findings. Investigations show that mobility has an impact on infection risk, but fewer data exist on the impact of geographic mobility on medical care and treatment outcomes. This review will examine existing data regarding the impact of geographic mobility on access to and maintenance in medical care and on adherence to antiretroviral therapy for those living with human immunodeficiency virus infection. It will also expand the concept of mobility to include data on the impact of the distance from residence to clinic on medical care and treatment adherence. Our conclusions are that the existing literature is limited by varying definitions of mobility and the inherent oversimplification necessary to apply a {"}mobility measure{"} in a statistical analysis. The impact of mobility on antiretroviral treatment outcomes deserves further exploration to both define the phenomenon and target interventions to these at-risk populations.",
keywords = "antiretroviral treatment, geographic mobility, human immunodeficiency virus HIV, mobile population",
author = "Barbara Taylor and Gardu{\~n}o, {L. Sergio} and Reyes, {Emily V.} and Raziel Vali{\~n}o and Rita Rojas and Yeycy Donastorg and Karen Brudney and Jennifer Hirsch",
year = "2011",
month = "5",
doi = "10.1002/msj.20255",
language = "English (US)",
volume = "78",
pages = "342--351",
journal = "Annals of Global Health",
issn = "0027-2507",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - HIV care for geographically mobile populations

AU - Taylor, Barbara

AU - Garduño, L. Sergio

AU - Reyes, Emily V.

AU - Valiño, Raziel

AU - Rojas, Rita

AU - Donastorg, Yeycy

AU - Brudney, Karen

AU - Hirsch, Jennifer

PY - 2011/5

Y1 - 2011/5

N2 - The interaction between geographic mobility and risk for human immunodeficiency virus infection is well recognized, but what happens to those same individuals, once infected, as they transition to living with the infection? Does mobility affect their transition into medical care? If so, do mobile and nonmobile populations achieve similar success with antiretroviral treatment? The definition of mobility has changed over the centuries to encompass a complex phenotype including permanent migration, frequent travel, circular migration, and travel to and from treatment centers. The heterogeneity of these definitions leads to discordant findings. Investigations show that mobility has an impact on infection risk, but fewer data exist on the impact of geographic mobility on medical care and treatment outcomes. This review will examine existing data regarding the impact of geographic mobility on access to and maintenance in medical care and on adherence to antiretroviral therapy for those living with human immunodeficiency virus infection. It will also expand the concept of mobility to include data on the impact of the distance from residence to clinic on medical care and treatment adherence. Our conclusions are that the existing literature is limited by varying definitions of mobility and the inherent oversimplification necessary to apply a "mobility measure" in a statistical analysis. The impact of mobility on antiretroviral treatment outcomes deserves further exploration to both define the phenomenon and target interventions to these at-risk populations.

AB - The interaction between geographic mobility and risk for human immunodeficiency virus infection is well recognized, but what happens to those same individuals, once infected, as they transition to living with the infection? Does mobility affect their transition into medical care? If so, do mobile and nonmobile populations achieve similar success with antiretroviral treatment? The definition of mobility has changed over the centuries to encompass a complex phenotype including permanent migration, frequent travel, circular migration, and travel to and from treatment centers. The heterogeneity of these definitions leads to discordant findings. Investigations show that mobility has an impact on infection risk, but fewer data exist on the impact of geographic mobility on medical care and treatment outcomes. This review will examine existing data regarding the impact of geographic mobility on access to and maintenance in medical care and on adherence to antiretroviral therapy for those living with human immunodeficiency virus infection. It will also expand the concept of mobility to include data on the impact of the distance from residence to clinic on medical care and treatment adherence. Our conclusions are that the existing literature is limited by varying definitions of mobility and the inherent oversimplification necessary to apply a "mobility measure" in a statistical analysis. The impact of mobility on antiretroviral treatment outcomes deserves further exploration to both define the phenomenon and target interventions to these at-risk populations.

KW - antiretroviral treatment

KW - geographic mobility

KW - human immunodeficiency virus HIV

KW - mobile population

UR - http://www.scopus.com/inward/record.url?scp=79956353955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956353955&partnerID=8YFLogxK

U2 - 10.1002/msj.20255

DO - 10.1002/msj.20255

M3 - Article

C2 - 21598261

AN - SCOPUS:79956353955

VL - 78

SP - 342

EP - 351

JO - Annals of Global Health

JF - Annals of Global Health

SN - 0027-2507

IS - 3

ER -